Tavros Therapeutics

About:

Tavros Therapeutics is an emerging biotechnology company that discovers and develops therapies for cancer.

Website: https://www.tavrostherapeutics.com/

Top Investors: Vividion Therapeutics, Alexandria Venture Investments, KdT Ventures, Piedmont Capital Investments

Description:

Tavros Therapeutics is an emerging biotechnology company that discovers and develops therapies for cancer. The company was founded in 2019 and based in Durham, North Carolina.

Total Funding Amount:

$28M

Headquarters Location:

Durham, North Carolina, United States

Founded Date:

2019-01-01

Founders:

Eoin McDonnell, Greg Mossinghoff

Number of Employees:

1-10

Last Funding Date:

2022-10-12

IPO Status:

Private

Industries: